Publisher Responsibility Disclaimer: The publisher of this article has made every effort to ensure accuracy at the time of publication based on publicly available information

CrossRef ADAM15 promotes the progression and metastasis of hepatocellular carcinoma by activating the JNK/p38 pathway Xu Junhui, Su Mengyun Scientific Reports .2026;[Epub] CrossRef Overcoming immune resistance in hepatocellular carcinoma: insights into mechanisms, predictive factors, and interventional strategies Zhenxao Wang, Jun Wu, Qiao Li, Xin Wen Frontiers in Immunology .2026;[Epub] CrossRef Characterization and regulatory mechanism evaluation of C8orf33 in hepatocellular carcinoma through multiomics profiling Wei Gao, Siyi Xing, Mingjiang Liu, Xing Xie, Mei Feng, Zhipeng Quan, Housheng Wang, Zhilong He, Qianxin Hu, Huizhao Su, Shuiping Yu, Zeyuan Li Discover Oncology .2026;[Epub] CrossRef Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis Qi Zhang, Zhenwu Lei, Hezi Qing, Xingwu Xie Frontiers in Immunology .2026;[Epub] CrossRef Mechanisms and Management Strategies of Hepatocarcinogenesis Driven by Chronic Hepatitis B Comorbid with Type 2 Diabetes Qin Lou, Jiarong Cai, Jianhua Yin Microorganisms .2026

GLP-1 analog use is associated with improved disease course in inflammatory bowel disease: a report from the Epi-IIRN
How to Use BPC 157 for Arthritis If you are considering BPC 157 as part of your arthritis management plan, here are some key guidelines for its use: Consult with a Healthcare Provider: Before starting BPC 157, consult with a healthcare provider or a knowledgeable practitioner
En yaygn glutatyon eitleri unlardr: Glutatyon kullanmnda en nemli unsur, vcudun bu bileii emebilme kapasitesidir